MeCure: Sustaining Momentum on Strong Fundamentals, Renewed FX Tailwinds
MeCure Industries Plc continues to ride a smooth upward trajectory on the Nigerian Exchange, buoyed by easing foreign exchange constraints, recently liberalised import access for essential medical equipment, and a resilient operational performance.
The company has maintained strong investor appeal, with market participants increasingly positioning on the back of strengthened confidence in the pharmaceutical manufacturer’s growth strategy and execution capacity.
The stock sustained an upward close in its latest trading session, opening at N29.80 and gaining N2.60 to finish at N32.40 per share. This positions the equity comfortably above its 50-day moving average of N28.58 and significantly higher than its 52-week low of N11.20, reflecting robust momentum and attractive re-rating by investors.
This sentiment is firmly anchored on MeCure’s stellar Q3 2025 financial performance. Revenue surged to N60 billion, nearly doubling the previous year’s N30.22 billion, representing a remarkable 99% growth. Profit before tax also accelerated sharply, rising from N5.03 billion to N13.02 billion, a 159% increase, while profit for the period jumped 166% year-on-year, climbing from N1.56 billion to N4.46 billion.
These financial gains mirror the company’s strategic expansion initiatives, including the commissioning of an ultra-modern manufacturing centre, which has bolstered production capacity and enhanced operational efficiency. The result is sustained traction on the NGX, supported by improved output, disciplined management focus, and a clearly defined growth path
Given the compelling value proposition, strong fundamentals, and positive market sentiment, MeCure Industries Plc earns a firm “BUY” recommendation. Its trajectory suggests further upside potential as investors continue to reprice the stock in line with its strengthening earnings profile and sector-wide tailwinds. #MeCure: Sustaining Momentum on Strong Fundamentals, Renewed FX Tailwinds#
High Short-term Debt: GCR Downgrades Mecure Industries Rating
